ChenGuang Biotech Group Co., Ltd.
300138.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.71B
Close$
Share Statistics
| Market cap | $5.71 Billion |
|---|---|
| Enterprise Value | $10.30 Billion |
| Dividend Yield | $0.30 (2.54%) |
| Earnings per Share | $0.76 |
| Beta | 0.55 |
| Outstanding Shares | 483,100,093 |
Return
| Return on Equity | 9.62% |
|---|---|
| Return on Assets | 3.40% |
| Return on Invested Capital | 9.72% |
Valuation & Multiples
| P/E Ratio | 17.13 |
|---|---|
| PEG | -76.31 |
| Price to Sales | 0.99 |
| Price to Book Ratio | 1.69 |
| Enterprise Value to Revenue | 1.7 |
| Enterprise Value to EBIT | 28.42 |
| Enterprise Value to Net Income | 31 |
| Total Debt to Enterprise | 0.55 |
| Debt to Equity | 1.66 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 26, 2026
EPS Estimate
$0.22
Average shareholder expectationRevenue Estimate
$1.53 B
Average shareholder expectationNext Earnings Call
Expected Date
October 27, 2026
EPS Estimate
$0.21
Average shareholder expectationRevenue Estimate
$1.53 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About ChenGuang Biotech Group Co., Ltd.
2,079 employees
CEO: Qingguo Lu ChenGuang Biotech Group Co., Ltd. is a key player in the development and production of natural ingredients. Its extensive product catalog encompasses natural colorants, including paprika and marigold oleoresins, as well as turmeric. The ...